Legionella Bacteria Outbreak Kills Two People in Berlin
IMAGO / Funke Foto Services The public health department has linked the deaths of two residents in the Berlinovo…
Berlin: Parkinson’s Linked to Pesticides Now a Recognized Occupational Disease in Germany
Germany’s federal cabinet added Parkinson’s disease caused by pesticide exposure to the official list of occupational diseases at…
Asian tiger mosquito spreads as far as Berlin: how dangerous is it?
By Diana Resnik Published on 31/05/2026 – 15:58 GMT+2 A species of mosquito from the tropics in Germany? The…
Novo Nordisk global observational study reveals 2 in 5 people with cardiovascular disease have cardiovascular inflammation, increasing their risk of heart attack and stroke
The Novo Nordisk study POSEIDON – including 18,904 patients across 18 countries – showed that cardiovascular (CV) inflammation…
Novo Nordisk Turns the Page: EU Backs Oral Wegovy as Liver Disease Data and a DKK 11.2bn Buyback Lif
Novo Nordisk launches DKK 11.2B buyback, receives EU approval for two new Wegovy formulations, posts strong oral tablet…
Novo Nordisk to unveil data showing semaglutide tackles the liver disease crisis affecting about 1 in 3 people living with overweight and obesity worldwide
Trial liver safety data from the ‘ESSENCE’ trial confirm semaglutide’s favourable hepatic profile in patients with Metabolic Dysfunction-associated…
Novo Nordisk’s Rare Disease Breakthrough Fails to Lift Oversold Shares
Novo Nordisk reports positive Phase 3 results for sickle cell drug etavopivat, but shares remain under pressure from…
WHO Foundation and Novo Nordisk expand collaboration to financially support health systems
WHO Foundation and Novo Nordisk expand collaboration to financially support health systems March 15, 2026 | Sunday |…
WHO Foundation and Novo Nordisk expand collaboration to financially support health systems
WHO Foundation and Novo Nordisk expand collaboration to financially support health systems March 15, 2026 | Sunday |…
All Eyes on Copenhagen for Neurodegenerative Disease Data
Denali Therapeutics’ stock surges 32.6% ahead of a pivotal data showcase at the AD/PD 2026 conference, where validation…